USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $0.64, $0.15 better than the analyst estimate of $0.49. Revenue for the quarter came in at $214 million versus the consensus estimate of $208.84 million.

GUIDANCE:

USANA Health Sciences sees FY2025 EPS of $2.35-$3.00, versus the consensus of $2.87. USANA Health Sciences sees FY2025 revenue of $920-1000 million, versus the consensus of $934.5 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.